[Vaginal virucides against HIV]

Area of Science:

• Microbiology
• Infectious Diseases
• Women's Health

Context:

• Despite ongoing efforts, HIV/AIDS remains a significant global health challenge, necessitating diverse prevention strategies.
• Existing methods like condoms, while effective, are not always consistently used or preferred by all individuals.
• There is a critical need for additional, woman-controlled prevention technologies to empower individuals in managing their sexual health.

Purpose:

• To introduce and discuss the development of virucides as a novel approach to HIV prevention.
• To highlight the potential of virucides as a woman-controlled, self-administered method for protection against HIV and other STIs.
• To outline the characteristics and advantages of virucides compared to existing prevention methods.

Summary:

• Virucides are anti-infective agents formulated for vaginal application, offering protection against HIV and other sexually transmitted pathogens.
• These agents are designed for self-administration by women, providing a discreet and controllable option for sexual health.
• Approximately 60 candidate virucides are in development, with several nearing large-scale clinical trials, indicating promising advancements.

Impact:

• Virucides offer a low-cost, woman-controlled option for self-administered, broad-spectrum protection.
• They provide a choice of contraceptive and non-contraceptive formulations, catering to diverse user needs.
• Successful development and implementation of virucides could significantly enhance global HIV/STI prevention efforts and reduce unintended pregnancies.